Global Information
회사소개 | 문의 | 비교리스트

인공 중요 장기 및 메디컬 바이오닉스 시장 : 유형별(인공 중요 장기, 메디컬 바이오닉스), 지역별 - 규모, 점유율, 전망, 기회 분석(2020-2027)

Artificial Vital Organs and Medical Bionics Market, By Type (Artificial Vital Organs, Medical Bionics ), and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

리서치사 Coherent Market Insights
발행일 2020년 06월 상품 코드 942052
페이지 정보 영문
가격
US $ 4,500 ₩ 5,029,000 PPT Turned PDF (Single User License)
US $ 7,000 ₩ 7,823,000 PPT Turned PDF (Multi-user License)
US $ 10,000 ₩ 11,177,000 PPT Turned PDF (Enterprise User License)


인공 중요 장기 및 메디컬 바이오닉스 시장 : 유형별(인공 중요 장기, 메디컬 바이오닉스), 지역별 - 규모, 점유율, 전망, 기회 분석(2020-2027) Artificial Vital Organs and Medical Bionics Market, By Type (Artificial Vital Organs, Medical Bionics ), and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
발행일 : 2020년 06월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 인공 중요 장기 및 메디컬 바이오닉스 시장을 조사했으며, 시장 역학, 규제, 동향 분석, 유형별, 지역별 분석, 경쟁 구도 등의 정보를 정리하여 전해드립니다.

목차

제1장 조사 목적과 전제

제2장 시장의 전망

  • 리포트의 개요
  • 시장의 정의와 범위
  • 개요
  • 유형별 시장
  • COM(Coherent Opportunity Map)

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
  • 촉진요인
  • 억제요인
  • 시장 기회
  • 영향 분석
  • 주요 동향
  • 기술 진보
  • 규제 시나리오

제4장 시장 분석 : 유형별

  • 서론
  • 시장 점유율 분석 : 2019년과 2027년
  • 전년대비 성장률 분석 : 2019-2027년
  • 부문 동향
  • 인공 중요 장기
    • 인공심장
    • 인공신장
    • 인공간
    • 인공췌장
    • 인공폐
  • 메디컬 바이오닉스
    • 인공와우
    • 인공 시각
    • 외골격
    • 인공 의지
    • 브레인 바이오닉스
    • 심장 바이오닉스

제5장 시장 분석 : 지역별

  • 서론
  • 시장 점유율 분석 : 2019년과 2027년
  • 전년대비 성장률 분석 : 2019-2027년
  • 부문 동향
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 러시아
    • 기타
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • ASEAN
    • 호주
    • 한국
    • 기타
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
    • 기타
  • 중동
    • GCC 회원국
    • 이스라엘
    • 기타
  • 아프리카
    • 북아프리카
    • 중앙아프리카
    • 남아프리카

제6장 경쟁 구도

  • 기업 개요
    • 회사 개요
    • 제품 포트폴리오
    • 주요 동향
    • 재무 실적
    • 전략
  • BiVACOR
  • CARMAT
  • Cleveland Heart
  • Jarvik Heart
  • MyLVAD
  • Cirtec Medical Systems
  • Thoratec Corporation
  • Abbott Diabetes Care, Inc.
  • Abiomed, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Cyberonics, Inc.
  • Edwards Lifesciences Corporation
  • 기타 기업

제7장

  • 참고 문헌
  • 조사 방법
KSA 20.07.01

Title:
Artificial Vital Organs and Medical Bionics Market, By Type (Artificial Vital Organs (Artificial Heart, Artificial Kidney, Artificial Liver, Artificial Pancreas, Artificial Lungs), Medical Bionics (Cochlear Implants, Vision Bionics, Exoskeletons, Bionic Limbs, Brain Bionics, Cardiac Bionics)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Artificial Vital Organs are man-made devices that are created to work like original diseases organ or to restore a specific function of that organ. These devices are implanted at the site of the diseased organ in the patient. Medical bionics is the study of application of mechanics and electronics for the replacement of a limb or other part of a functional organ that is mechanically powered. Artificial organs can be an artificial heart, artificial kidney, artificial pancreas and others. An artificial organ consists of different parts that mimic functions of the original organ. For instance, artificial pancreas systems comprise of devices that are already used in diabetes management such as Continuous glucose monitoring (CGM) device, insulin pump, blood glucose device (BGD), and digital control device with control algorithm. Artificial pancreas systems are compatible with existing pumps and CGMs and its control functions can be integrated into a regular smartphone.

Restraints of the Global Artificial Vital Organs and Medical Bionics Market

Major factors hampering the growth of the Artificial Vital Organs and Medical Bionics market during the forecast period constitutes of criticism associated with artificial organ transplant, and high costs.

Key features of the study:

  • This report provides in-depth analysis of the global Artificial Vital Organs and Medical Bionics market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global Artificial Vital Organs and Medical Bionics market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include SynCardia Systems, LLC, BiVACOR, CARMAT, Cleveland Heart, Jarvik Heart, MyLVAD, Cirtec Medical Systems, Thoratec Corporation, Abbott Diabetes Care, Inc., Abiomed, Inc., Asahi Kasei Medical Co., Ltd., Cyberonics, Inc., Edwards Lifesciences Corporation, Ekso Bionics Holdings, Inc., F. Hoffmann-La Roche Ltd., Fresenius Medical Care AG & Co. KGaA, Gambro AB (Baxter International, Inc.), and iWalk, Inc.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global Artificial Vital Organs and Medical Bionics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Artificial Vital Organs and Medical Bionics Market, By Type:
  • Artificial Vital Organs
  • Artificial Heart
  • Artificial Kidney
  • Artificial Liver
  • Artificial Pancreas
  • Artificial Lungs
  • Medical Bionics
  • Cochlear Implants
  • Vision Bionics
  • Exoskeletons
  • Bionic Limbs
  • Brain Bionics
  • Cardiac Bionics
  • Global Artificial Vital Organs and Medical Bionics Market, By Geography:
  • North America
  • By Type
  • Artificial Vital Organs
    • Artificial Heart
    • Artificial Kidney
    • Artificial Liver
    • Artificial Pancreas
    • Artificial Lungs
  • Medical Bionics
    • Cochlear Implants
    • Vision Bionics
    • Exoskeletons
    • Bionic Limbs
    • Brain Bionics
    • Cardiac Bionics
  • By Country:
  • U.S.
  • Canada
  • Europe
  • By Type
  • Artificial Vital Organs
    • Artificial Heart
    • Artificial Kidney
    • Artificial Liver
    • Artificial Pancreas
    • Artificial Lungs
  • Medical Bionics
    • Cochlear Implants
    • Vision Bionics
    • Exoskeletons
    • Bionic Limbs
    • Brain Bionics
    • Cardiac Bionics
  • By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Type
  • Artificial Vital Organs
    • Artificial Heart
    • Artificial Kidney
    • Artificial Liver
    • Artificial Pancreas
    • Artificial Lungs
  • Medical Bionics
    • Cochlear Implants
    • Vision Bionics
    • Exoskeletons
    • Bionic Limbs
    • Brain Bionics
    • Cardiac Bionics
  • By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • By Type
  • Artificial Vital Organs
    • Artificial Heart
    • Artificial Kidney
    • Artificial Liver
    • Artificial Pancreas
    • Artificial Lungs
  • Medical Bionics
    • Cochlear Implants
    • Vision Bionics
    • Exoskeletons
    • Bionic Limbs
    • Brain Bionics
    • Cardiac Bionics
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East:
  • By Type
  • Artificial Vital Organs
    • Artificial Heart
    • Artificial Kidney
    • Artificial Liver
    • Artificial Pancreas
    • Artificial Lungs
  • Medical Bionics
    • Cochlear Implants
    • Vision Bionics
    • Exoskeletons
    • Bionic Limbs
    • Brain Bionics
    • Cardiac Bionics
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Type
  • Artificial Vital Organs
    • Artificial Heart
    • Artificial Kidney
    • Artificial Liver
    • Artificial Pancreas
    • Artificial Lungs
  • Medical Bionics
    • Cochlear Implants
    • Vision Bionics
    • Exoskeletons
    • Bionic Limbs
    • Brain Bionics
    • Cardiac Bionics
  • By Country/Region:
  • Central Africa
  • South Africa
  • North Africa
  • Company Profiles
  • SynCardia Systems, LLC*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • BiVACOR
  • CARMAT
  • Cleveland Heart
  • Jarvik Heart
  • MyLVAD
  • Cirtec Medical Systems
  • Thoratec Corporation
  • Abbott Diabetes Care, Inc.
  • Abiomed, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Cyberonics, Inc.
  • Edwards Lifesciences Corporation
  • Other Major Players

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
    • Market Definition and Scope
    • Executive Summary
    • Market Snippet, By Type
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Technological Advancement
    • Regulatory Scenario

4. Global Artificial Vital Organs and Medical Bionics Market, By Type, 2017 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • Artificial Vital Organs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Artificial Heart
    • Artificial Kidney
    • Artificial Liver
    • Artificial Pancreas
    • Artificial Lungs
    • Medical Bionics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Cochlear Implants
    • Vision Bionics
    • Exoskeletons
    • Bionic Limbs
    • Brain Bionics
    • Cardiac Bionics

5. Global Artificial Vital Organs and Medical Bionics Market, By Regions, 2017 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • U.S.
    • Canada
    • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

6. Competitive Landscape

    • Company Profiles
    • SynCardia Systems, LLC
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • BiVACOR
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • CARMAT
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Cleveland Heart
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Jarvik Heart
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • MyLVAD
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Cirtec Medical Systems
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Thoratec Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Abbott Diabetes Care, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Abiomed, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Asahi Kasei Medical Co., Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Cyberonics, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Edwards Lifesciences Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Other Major Players
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

7. Section

    • References
    • Research Methodology
    • About us and Sales Contact
Back to Top
전화 문의
F A Q